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CASE REPORT
Bilateral endoprosthetic replacements of the proximal femur
ATHANASIOS F. FOUKAS & ROBERT J. GRIMER
Royal Orthopaedic Hospital Oncology Service, Birmingham, UK
Abstract
Patient. We report the case of a 20-year-old caucasian male with an Ewing’s sarcoma in the left upper femur. After
induction chemotherapy, he underwent resection of the left upper femur and insertion of a cemented proximal femoral
replacement. Four years later, he presented with a solitary bone metastasis in the right upper femur. He underwent further
chemotherapy followed by resection and endoprosthetic replacement of the other proximal femur. He remains disease free
with excellent function almost a year after the second operation.
Discussion. We believe this is the ® rst reported case of bilateral proximal femoral endoprostheses.
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Introduction
Limb-salvage surgery is now possible in 85% of
patients with primary sarcomas of bone.
Re® nements in surgical techniques and chemo-
therapy regimes also mean that patients are living
longer and hence the effectiveness of the limb-sal-
vage surgery and its durability is also becoming
increasingly important.
1± 5 As patients survive longer,
unusual patterns of metastatic disease are appearing
and these present their own problems in treat-
mentÐ both surgically and oncologically. We report
a case of Ewing’s sarcoma in which a solitary bone
metastasis developed in the contra-lateral proximal
femur 4
1
2 years after endoprosthetic replacement and
chemotherapy for Ewing’s sarcoma of the left proxi-
mal femur. It was treated with a second proximal
femoral endoprosthesis. We believe this is the ® rst
reported case of bilateral proximal femoral endo-
prosthetic replacements for primary bone tumour.
Case history
A 20-year-old white Caucasian male was referred to
us in July 1991 with a 25-week history of pain in the
left upper femur. Radiographic imaging and biopsy
con® rmed Ewing’s sarcoma with extensive soft tis-
sue disease (Figs 1 and 2). He received induction
chemotherapy with IVAD (ifosfamide, vincristine,
adriamycin, actinomycin D) and after four cycles he
underwent resection of the proximal femur and in-
sertion of a cemented proximal femoral replacement
replacing 61% of the femur. Pathological evaluation
showed greater than 95% necrosis of the tumour
with wide margins of resection.
Fig. 1. Initial X-rays of the primary tumour in the left femur.
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Fig. 2. Bone scan: primary Ewing’s sarcoma in the left upper
femur.
Discussion
The outcome of Ewings sarcoma treatment has im-
proved dramatically with chemotherapy and surgery
for patients who present free of metastatic disease.
Disease-free survival of 65% at 5 years is reported.
2,6
Most relapses occur within the ® rst 2 years.
1± 3,5± 7
Relapse at 4
1
2 years with a solitary bone metastasis is
unusual but not unique. A late relapse at the same
site as the initial tumour is exceedingly unusual.
The prognosis for patients who relapse is poor
with 20% survival at 3 years in the CESS 86 Study.
6
However, it has been shown in the same series that
if the time to relapse is greater than 24 months from
original diagnosis, then the prognosis improves con-
siderably, and in the CESS 86 series
3
4 patients with
bone metastasis appearing later than 24 months
from diagnosis were still disease free at 4 years
following relapse. Aggressive treatment with further
chemotherapy and wide excisional surgery is clearly
justi® ed in these cases.
Endoprosthetic replacement of the proximal fe-
mur is a well established surgical technique for
replacing tumours of the upper femur.
8± 10 One of
the main disadvantages of this method is the loss of
muscle and in particular the removal of the abductor
Fig. 3. Pathological fracture through the secondary lesion in
the right femur.
He did very well, regaining near normal function
and achieving an Enneking functional score of 29
out of 30 (96%) at follow-up 4 years later. In
February 1996, he started to get right thigh pain and
was found to have a solitary bone metastasis in the
right upper femur. He was started on induction
chemotherapy with EVAIA (etoposide, vincristine,
adriamycin ifosfamide, actinomycin D) and was
kept non-weight-bearing on crutches. After the ® rst
cycle of chemotherapy, he fell and sustained a
pathological fracture through the right proximal fe-
mur (Fig. 3). He was admitted to hospital for trac-
tion and further chemotherapy. After two further
cycles of chemotherapy, he underwent resection of
the upper femur and insertion of a second endopros-
thetic replacement, this time replacing 45% of the
bone. Ten days post-operatively, he was up walking
on crutches and was discharged after 14 days. His-
tology showed 50% necrosis of the tumour with
clear margins of resection. By 8 months following
the second surgery the patient was walking without
any sticks. Trendelenburgh is negative on the left
but delayed positive on the right side. The func-
tional score is 76% on the right and 90% on the left
side (Fig. 4). After 18 months he relapsed with
further widespread bony metastases.Bilateral endoprosthetic replacements of the proximal femur 51
Fig. 4. PA ® lm 14 days after the right proximal femoral
endoprosthesis (patient upright).
young and well motivated and we would anticipate
good functional recovery. The prognosis is clearly
uncertain. We ® rmly believe that aggressive surgical
reconstruction combined with chemotherapy is
justi® ed for these unusual cases.
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lever arm from its insertion of the greater
trochanter. In all our patients the abductors are
reattached to the fascia lata and while this can
achieve a good functional abductor arm particularly
in younger patients, most people will have a slight
Trendelenberg dip and older patients frequently
need to use a walking stick.
Another approach would be to treat with chemo-
therapy and local radiotherapy. Damron et al.
reported a 79% rate of pathological fracture follow-
ing treatment of Ewings sarcoma of the proximal
femur with radiotherapy. Increasing evidence sug-
gests that the surgical management of primary
Ewing’s sarcoma does give improved rate of both
survival and local control.
11,12
We know of no case where bilateral endopros-
thetic replacements of the upper femur for primary
bone tumours have been carried out. The patient is